Revelation Financial Statements From 2010 to 2025

REVBW Stock  USD 0.02  0.0006  3.75%   
Revelation Biosciences financial statements provide useful quarterly and yearly information to potential Revelation Biosciences investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Revelation Biosciences financial statements helps investors assess Revelation Biosciences' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Revelation Biosciences' valuation are summarized below:
Earnings Share
(4.77)
There are over ninety-nine available trending fundamental ratios for Revelation Biosciences, which can be analyzed over time and compared to other ratios. All traders should should check out Revelation Biosciences' recent fundamental trends against the trends from 2010 to 2025 to make sure the company is sustainable. Market Cap is likely to drop to about 62.7 M in 2025. Enterprise Value is likely to drop to about 57 M in 2025
Check Revelation Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revelation Biosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 7 M, Total Operating Expenses of 8.4 B or Depreciation And Amortization of 38 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0028. Revelation financial statements analysis is a perfect complement when working with Revelation Biosciences Valuation or Volatility modules.
  
Check out the analysis of Revelation Biosciences Correlation against competitors.
For more information on how to buy Revelation Stock please use our How to Invest in Revelation Biosciences guide.

Revelation Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total AssetsB6.6 B850 M
Slightly volatile
Other Current Liabilities1.2 B1.1 B145.4 M
Slightly volatile
Total Current LiabilitiesB1.9 B246 M
Slightly volatile
Non Current Assets Total59.1 M56.3 M11.8 M
Slightly volatile
Common Stock Shares Outstanding1.8 M1.7 M241.7 K
Slightly volatile
Liabilities And Stockholders EquityB6.6 B850 M
Slightly volatile
Total LiabilitiesB1.9 B246 M
Slightly volatile
Accounts Payable822.8 M783.6 M101.2 M
Slightly volatile
Cash6.8 B6.5 B836.9 M
Slightly volatile
Cash And Short Term Investments6.8 B6.5 B836.9 M
Slightly volatile
Short Term Investments420.2 K472.8 K515.4 K
Slightly volatile
Other Current Assets70 M66.7 M8.7 M
Slightly volatile
Other Stockholder Equity47.5 B45.2 B5.8 B
Slightly volatile
Total Current Assets6.9 B6.6 B845.6 M
Slightly volatile
Capital Stock496522747 K
Pretty Stable
Common Stock548.1 K522 K68.7 K
Slightly volatile
Short and Long Term Debt Total13.4 K15.1 K16.4 K
Slightly volatile
Short Term Debt3.5 M3.3 M805.4 K
Slightly volatile
Current Deferred Revenue2.3 M2.6 M2.9 M
Slightly volatile

Revelation Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Other Operating ExpensesM10 MM
Slightly volatile
Total Operating Expenses8.4 BBB
Slightly volatile
Depreciation And Amortization38 K28.8 K15.2 K
Slightly volatile
Selling General Administrative4.6 B4.4 B568.1 M
Slightly volatile
Selling And Marketing Expenses21.4 K22.5 K106.6 K
Slightly volatile
Research Development3.7 B3.5 B455.7 M
Slightly volatile
Interest Expense30.7 K31.5 K39.6 K
Slightly volatile
Cost Of Revenue35.8 K22.5 K59.6 K
Slightly volatile
Reconciled Depreciation26.1 K27.9 K19.1 K
Slightly volatile

Revelation Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
End Period Cash Flow6.8 B6.5 B880.2 M
Slightly volatile
Stock Based Compensation177.3 M168.8 M21.7 M
Slightly volatile
Begin Period Cash Flow12.6 B12 B1.6 B
Slightly volatile
Total Cash From Financing Activities13.5 B12.8 B1.7 B
Slightly volatile
Depreciation29.3 M27.9 M3.6 M
Slightly volatile
Issuance Of Capital Stock7.8 M5.4 M8.4 M
Pretty Stable
Dividends Paid6.1 M6.9 M7.5 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables656.5 K1.1 M585.1 K
Slightly volatile
Capex To Depreciation7.0E-47.0E-45.8976
Slightly volatile
Payables Turnover0.02010.02120.0952
Slightly volatile
Cash Per ShareK3.8 K914
Slightly volatile
Days Payables Outstanding18.7 K17.8 K6.2 K
Slightly volatile
Income Quality1.161.21834.1488
Slightly volatile
Net Debt To EBITDA8.0E-48.0E-429.1372
Very volatile
Current Ratio3.6 K3.4 K442
Slightly volatile
Capex Per Share0.01060.011210.5289
Slightly volatile
Interest Debt Per Share1.421.61.7479
Slightly volatile
Debt To Assets0.00660.00740.008
Slightly volatile
Days Of Payables Outstanding18.7 K17.8 K6.2 K
Slightly volatile
Ebt Per Ebit2.951.88571.7532
Pretty Stable
Effective Tax Rate0.00350.003729.5273
Slightly volatile
Quick Ratio3.6 K3.4 K442
Slightly volatile
Net Income Per E B T0.80.90.9784
Slightly volatile
Cash Ratio1.773.39613.1236
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.151.0253
Slightly volatile
Debt Ratio0.00660.00740.008
Slightly volatile

Revelation Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap62.7 M66 M1.1 B
Slightly volatile
Enterprise Value57 M60 M1.1 B
Slightly volatile

Revelation Fundamental Market Drivers

Cash And Short Term Investments6.5 B

About Revelation Biosciences Financial Statements

Revelation Biosciences investors use historical fundamental indicators, such as Revelation Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revelation Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.6 M2.3 M
Cost Of Revenue22.5 K35.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Revelation Stock Analysis

When running Revelation Biosciences' price analysis, check to measure Revelation Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revelation Biosciences is operating at the current time. Most of Revelation Biosciences' value examination focuses on studying past and present price action to predict the probability of Revelation Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revelation Biosciences' price. Additionally, you may evaluate how the addition of Revelation Biosciences to your portfolios can decrease your overall portfolio volatility.